Karo Bio's annual general meeting

KARO BIO'S ANNUAL GENERAL MEETING At Karo Bio's Annual General Meeting, April 26, 2001 the following was resolved. Dividend No dividend is to be paid for the financial year 2000. Board of Directors Dana M. Fowlkes re-election Bertil Hållsten re-election Peter Kushner re-election Lars Ingelmark re-election Per-Olof Mårtensson re-election Dan Sten Olsson re-election Leon E. Rosenberg re-election John D. Baxter deputy, re-election Jan-Åke Gustafsson deputy, re-election Per Otteskog deputy, re-election At the Board Meeting following the Annual Meeting, Per-Olof Mårtensson was elected Chairman of the Board. Nomination Committee Dan Sten Olsson, Per-Olof Mårtensson and Kenth Petersson were elected Nomination Committee. Incentive Program The Annual General Meeting decided to issue debentures with 340,000 detachable warrants, in accordance with the Board's proposal, as a step in an incentive program for the staff and certain advisors. The share capital can due to that increase by SEK 1,700,000. Authorization for New Share Issue To authorize the Board to resolve on an issue of new shares with or without deviation from the shareholders' preferential rights of no more than 1,200,000 shares, the share capital can by that increase by SEK 6,000,000. Huddinge, April 26, 2001 KARO BIO AB (publ) Information For further information, please contact Per Otteskog, Acting President, phone +46-8-608 60 18, or Bertil Jungmar, Vice President Finance & Administration, phone +46 8 608 60 52. ------------------------------------------------------------ This information was brought to you by BIT http://www.bit.se The following files are available for download: http://www.bit.se/bitonline/2001/04/26/20010426BIT02590/bit0001.doc http://www.bit.se/bitonline/2001/04/26/20010426BIT02590/bit0001.pdf

About Us

Karo Pharma is a specialty pharma company that develops and markets products to pharmacies and directly to healthcare providers. The share is listed on Nasdaq Stockholm in the Mid Cap segment.

Subscribe